in

Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference

NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) will participate in Citi’s 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson–johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html

SOURCE Johnson & Johnson

Written by Tenner Smith

Tenner Smith - I have experience in financial intelligence and automated intelligence. In industry I have worked on artificial intelligence and machine learning. Tenner Smith is a reporter at DF media.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of FirstCash, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2022 – (FCFS)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alfi, Inc. of Class Action Lawsuit and Upcoming Deadline – ALF; ALFIW